Over the past five years, intravenous ultrasound contrast imaging has gone from a technique that had a few limited right-sided applications (e.g., detecting a patent foramen ovale) to one that has the potential to become an allencompassing imaging technique for both the determination of global and regional left ventricular (LV) systolic function and the rapid assessment of myocardial perfusion. If this potential becomes a reality, functional perfusion imaging will be possible in clinical situations where other imaging techniques (radionuclide imaging, computed tomography, right and left heart catheterization) simply cannot go-to the bedside. In this issue of the Journal, Reilly et al.
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demonstrating the value of harmonic imaging with intravenous Optison during bedside transthoracic echocardiography in the intensive care unit (ICU) (1) . Seventy patients, examined from April to June 1998, were randomly evaluated to determine whether harmonic imaging with an intravenous ultrasound contrast agent improved the reader's confidence in assessing wall motion and the global LV ejection fraction. They found that contrast imaging permitted the interpretation of 76% of the segments that could not be seen with standard imaging. More importantly, the authors found that they could interpret LV ejection fractions in 11 of the 16 patients in whom ejection fractions were uninterpretable with standard imaging and in 4 of the 9 patients whose ejection fractions were uninterpretable with harmonic imaging alone. Contrast echocardiography significantly changed the estimation of ejection fractions determined with standard imaging in 31 of the 70 patients. These data demonstrate the marked potential of intravenous contrast agents in intensive care settings, even when compared with standard harmonic imaging alone.
The importance of intravenous perfluorocarbon containing microbubbles. The findings of Reilly et al. (1) demonstrate that intravenous perfluorocarbon containing microbubbles can significantly improve the quality of the echocardiogram in the ICU. Previous studies using room air containing microbubbles (Levovist and Albunex [2, 3] ) have failed to demonstrate that these contrast agents added significantly to the endocardial border enhancement of harmonic imaging alone. Unlike these studies, Reilly et al.
(1) demonstrate the value of both harmonic imaging and perfluorocarbon containing microbubbles. Although harmonic imaging improved the quality of wall motion as compared with standard imaging, more than 20 patients in the ICU had a significant change in their ejection fraction estimation after the injection of intravenous Optison as compared with harmonic imaging alone. Although Reilly et al. (1) did not compare Optison with room air containing microbubbles, the value of perfluorocarbon containing microbubbles over room air containing microbubbles in delineating endocardial borders has been described in a recent phase III multicenter trial using the perfluorocarbon emulsion EchoGen (4).
Study limitations.
Although the report by Reilly et al. (1) is very important, it did not address some clinically relevant questions regarding the accuracy and utility of contrast echocardiography. First, we do not know if the increased "surety" after intravenous Optison correlated with increased accuracy. Because no comparative procedures were done on any of the patients (e.g., radionuclide imaging, left ventriculography), we cannot be sure that the ejection fractions with contrast imaging were entirely correct. For example, both diagnostic ultrasound pressures and LV systolic pressures destroy contrast microbubbles. Therefore, it is possible that the end-systolic images with contrast echocardiography falsely appeared smaller than they actually were owing to destroyed contrast agent. Hundley et al. (5) have shown, however, that there is a strong correlation between enddiastolic and end-systolic volumes obtained after contrast opacification with intravenous EchoGen and those obtained with magnetic resonance imaging. In this study, use of an intravenous contrast agent improved the number of ejection fractions that were correctly classified by echocardiography from 71% to 94%. Furthermore, the improved accuracy of contrast echocardiography was seen for ejection fractions that ranged from Ͻ35% to Ͼ50% (2).
Secondly, the authors (1) do not relate to us in what direction contrast imaging changed the ejection fractionfor the better or for the worse. For example, are the 44% of cases in which a significant change in ejection fractions occurred after use of contrast agent mainly the result of 
